A total of 10 individuals with HIV have been cured to date. Most of these patients have remained anonymous, but three have ...
MedPage Today on MSN
CDC Backs Twice-Yearly Injectable for HIV Prevention
The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir ...
Lenacapavir has delivered impressive trial results and, in July, it received official backing from the World Health ...
Indian drugmakers Dr Reddy's Laboratories and Hetero Labs said on Wednesday that they will sell generic versions of a new and ...
2don MSN
As Trump administration cuts HIV research funding, Atlanta doctors warn of impact on clinics
As HIV diagnoses continue increasing in metro Atlanta, the number of dollars for research and treatment is going down.
All adults who have blood taken as part of their treatment will have the sample tested for HIV, hepatitis B and hepatitis C, ...
Cheap generic versions of a groundbreaking HIV-prevention jab should be available in more than 100 countries from 2027, ...
A twice-yearly injection described as the most promising HIV prevention tool in decades is poised to reach millions more ...
World Politics Review on MSN
A Landmark Deal on HIV Prevention
Two partnerships will provide millions of people access to what is widely described as the most effective HIV prevention drug ...
WALB on MSN
Albany to host HIV awareness event
ALBANY, Ga. (WALB) - A local event aimed at raising awareness for HIV will take place this Saturday in Albany. The event will ...
Generic versions of a groundbreaking injectable HIV-prevention drug should be available for $40 a year in more than 100 ...
Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results